Back to search
A phase I clinical and pharmacokinetic study of the topoisomerase I inhibitor topotecan (SK&F 104864) given as an intravenous bolus every 21 days
Data up to Jan 2025
Published1992
Citations112
References0
Clinical Trials (1)
Total Citations Per Year
Abstract
References (0)
No references found
Cited By (0)
No citing papers found in database